Pycnodysostosis: Natural history and management guidelines from 27 French cases and a literature review.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
10 2019
Historique:
received: 29 03 2019
revised: 29 05 2019
accepted: 03 06 2019
pubmed: 27 6 2019
medline: 4 9 2020
entrez: 26 6 2019
Statut: ppublish

Résumé

Pycnodysostosis is a lysosomal autosomal recessive skeletal dysplasia characterized by osteosclerosis, short stature, acro-osteolysis, facial features and an increased risk of fractures. The clinical heterogeneity of the disease and its rarity make it difficult to provide patients an accurate prognosis, as well as appropriate care and follow-up. French physicians from the OSCAR network have been asked to fill out questionnaires collecting molecular and clinical data for 27 patients issued from 17 unrelated families. All patients showed short stature (mean = -3.5 SD) which was more severe in females (P = .006). The mean fracture rate was moderate (0.21 per year), with four fractures in total average. About 75% underwent at least one surgery, with an average number of 2.1 interventions per patient. About 50% required non-invasive assisted ventilation due to sleep apnea (67%). About 29% showed psychomotor difficulties and 33% needed a school assistant or adapted schooling. No patient had any psychological evaluation or follow-up. Molecular data were available for 14 families. Growth hormone administration was efficient on linear growth in 40% of cases. We propose several axis of management, such as systematic cerebral MRI for Chiari malformation screening at diagnosis and regular psychological follow-up.

Identifiants

pubmed: 31237352
doi: 10.1111/cge.13591
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-316

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Maroteaux P, Lamy M. Pyknodysostosis. Press Med. 1962;70:999-1002.
Maroteaux P, Lamy M. Two cases of a condensing osseous disease: pynodysostosis. Arch Fr Pediatr. 1962;19:267-274.
Xue Y, Cai T, Shi S, et al. Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011. Orphanet J Rare Dis. 2011;6(1):20.
Arman A, Bereket A, Coker A, et al. Cathepsin K analysis in a pycnodysostosis cohort: demographic, genotypic and phenotypic features. Orphanet J Rare Dis. 2014;9(1):60. https://doi.org/10.1186/1750-1172-9-60.
Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009;4(1):5.
Bertola D, Amaral C, Kim C, Albano L, Aguena M, Passos-Bueno MR. Craniosynostosis in pycnodysostosis: broadening the spectrum of the cranial flat bone abnormalities. Am J Med Genet A. 2010;152A(10):2599-2603.
Baglam T, Binnetoglu A, Fatih Topuz M, et al. Pycnodysostosis at otorhinolaryngology. Int J Pediatr Otorhinolaryngol. 2017;95(Supplement C):91-96.
Khoja A, Fida M, Shaikh A. Pycnodysostosis with special emphasis on dentofacial characteristics. Case Rep Dent. 2015;2015:1-6.
da Silva VP, Visioli F, Maraschin BJ, et al. Oral lesions in pycnodysostosis syndrome: eleven years of follow-up. J Craniofac Surg. 2016;27(7):e617-e618.
Balaji MSA, Sundaram RKS, Karthik P, Asokan K. Pycnodysostosis: a bone dysplasia with unusual oral manifestation. Indian J Dent. 2014;5(4):218-221.
Manfredi L, Leboulanger N, Garabedian E, Marlin S. Pycnodysostose révélée par un stridor atypique, série de cas et revue de la littérature. http://www.em-consulte.com/en/article/839258. Accessed June 7, 2017.
Durmaz CD, Taş V, Kocaay P, et al. Bilateral choanal atresia in an adult woman with pycnodysostosis. Congenit Anom. 2017;57(3):91-92. https://doi.org/10.1111/cga.12204.
Baruah RK, Haque R. Accordion maneuver with modified ilizarov frame for treatment of recalcitrant nonunion of shaft of femur in a patient with pycnodysostosis. J Clin Orthop Trauma. 2016;7(Supplement 1):45-47.
Martí PR, Font RU. Orthopaedic disorders of pycnodysostosis: a report of five clinical cases. Int Orthop. 2016;40(11):2221-2231.
Rojas PI, Niklitschek NE, Sepúlveda MF. Multiple long bone fractures in a child with pycnodysostosis. A case report. Arch Argent Pediatr. 2016;114(3):e179-e183.
Emami-Ahari Z, Zarabi M, Javid B. Pycnodysostosis. J Bone Joint Surg Br. 1969;51(2):307-312.
Girbal I, Nunes T, Medeira A, Bandeira T. Pycnodysostosis with novel gene mutation and severe obstructive sleep apnoea: management of a complex case. BMJ Case Rep. 2013;2013:bcr2013200590.
Fénelon M, Catros S, Boisramé S, et al. Complications maxillo-faciales associées à la pycnodysostose : présentation de deux cas cliniques et revue de la littérature. Méd Buccale Chir Buccale. 2015;21(3):169-176.
Ortegosa MV, Bertola DR, Aguena M, Passos-Bueno MR, Kim CA, de Faria MEJ. Challenges in the orthodontic treatment of a patient with pycnodysostosis. Cleft Palate Craniofac J. 2014;51(6):735-739.
Ferguson JW, Brown RH, Cheong LY. Pycnodysostosis associated with delayed and ectopic eruption of permanent teeth. Int J Paediatr Dent. 1991;1(1):35-38.
Jiang T, Liu F, Wang W-G, et al. Distribution of cathepsin K in late stage of tooth germ development and its function in degrading enamel matrix proteins in mouse. PLoS One. 2017;12(1):e0169857.
Aynaou H, Skiker I, Latrech H. Short stature revealing a pycnodysostosis: a case report. J Orthop Case Rep. 2016;6(2):43-45.
Mujawar Q, Naganoor R, Patil H, Thobbi AN, Ukkali S, Malagi N. Pycnodysostosis with unusual findings: a case report. Cases J. 2009;2:6544.
Shuler SE. Pycnodysostosis. Arch Dis Child. 1963;38(202):620-625.
Valdes-Flores M, Hidalgo-Bravo A, Casas-Avila L, et al. Molecular and clinical analysis in a series of patients with pyknodysostosis reveals some uncommon phenotypic findings. Int J Clin Exp Med. 2014;7(11):3915-3923.
Zheng H, Zhang Z, He J-W, Fu W-Z, Zhang Z-L. A novel mutation (R122Q) in the cathepsin K gene in a Chinese child with pyknodysostosis. Gene. 2013;521(1):176-179.
Soliman AT, Rajab A, AlSalmi I, Darwish A, Asfour M. Defective growth hormone secretion in children with pycnodysostosis and improved linear growth after growth hormone treatment. Arch Dis Child. 1996;75(3):242-244.
Karamizadeh Z, Ilkhanipoor H, Bagheri F. Effect of growth hormone treatment on height velocity of children with pycnodysotosis. Iran J Pediatr. 2014;24(2):161-165.
Darcan S, Akisü M, Taneli B, Kendir G. A case of pycnodysostosis with growth hormone deficiency. Clin Genet. 1996;50(5):422-425.
Donnarumma M, Regis S, Tappino B, et al. Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis. Hum Mutat. 2007;28(5):524.
Hou WS, Brömme D, Zhao Y, et al. Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest. 1999;103(5):731-738.
Fujita Y, Nakata K, Yasui N, et al. Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization. J Clin Endocrinol Metab. 2000;85(1):425-431.
Mandal K, Ray S, Saxena D, et al. Pycnodysostosis: mutation spectrum in five unrelated Indian children. Clin Dysmorphol. 2016;25(3):113-120.
Araujo TF, Ribeiro EM, Arruda AP, et al. Molecular analysis of the CTSK gene in a cohort of 33 Brazilian families with pycnodysostosis from a cluster in a Brazilian northeast region. Eur J Med Res. 2016;21(1):33.

Auteurs

Varoona Bizaoui (V)

Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France.

Caroline Michot (C)

Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France.

Geneviève Baujat (G)

Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France.

Cyril Amouroux (C)

Department of Paediatric Endocrinology, Arnaud de Villeneuve Hospital, Montpellier, France.

Sabine Baron (S)

Service de Génétique Médicale, CHU de Nantes, Nantes, France.

Yline Capri (Y)

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.

Martine Cohen-Solal (M)

Department of Rheumatology, Lariboisière Hospital, INSERM U1132 and University Paris-Diderot, Paris, France.

Corinne Collet (C)

Department of Biochemistry, APHP, Saint-Louis Lariboisière Hospitals, Paris, France.

Anne Dieux (A)

Centre de Référence CLAD NdF, Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, France.

David Geneviève (D)

Service de Génétique Clinique et du Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Compétence Maladies Osseuses Constitutionnelles, Inserm U1183, Université Montpellier, Montpellier, France.

Bertrand Isidor (B)

Service de Génétique Médicale, CHU de Nantes, Nantes, France.

Sophie Monnot (S)

Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France.

Massimiliano Rossi (M)

Hospices Civils de Lyon, Service de Génétique, Centre de Référence Anomalies du Développement, Bron, France.
Centre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, UCB Lyon 1, Lyon, France.

Anya Rothenbuhler (A)

Department of Paediatric Endocrinology, Bicêtre Hospital, Paris, France.

Elise Schaefer (E)

Service de Génétique Médicale, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Valérie Cormier-Daire (V)

Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH